Lilly boosts oral GLP-1 manufacturing capability with new Netherlands facility
By Catherine Eckford (European Pharmaceutical Review)
CPHI Europe adds AI and tech zone for its return to Milan in 2026
By Dominic Tyer (European Pharmaceutical Review)
MHRA set to overhaul the UK’s rare disease drug regulatory pathway
By Catherine Eckford (European Pharmaceutical Review)
Pfizer and Novo Nordisk battle for obesity market dominance
By Catherine Eckford (European Pharmaceutical Review)
Simplified rAAV lysate purification for complex analytics of upstream samples
By Marko Narobe (Sartorius Biosepartions), Michael Gerrero (BridgeBio), Srivatsan Ramesh…






























